CHRISTINE DURHAM-PRESSLEY: Open Payments
NPI 1144861063 · FEDERALSBURG, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$277 in 14 payments from 9 companies in 2025. Trend: 2023 $176 · 2024 $360 · 2025 $277
Food & beverage: $277
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $79 |
| Exact Sciences Corporation | 3 | $64 |
| Astellas Pharma US Inc | 1 | $31 |
| Hologic Sales and Service, LLC | 1 | $22 |
| Corcept Therapeutics | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: MOUNJARO, The Cologuard Plus Collection Kit, Veozah, APTIMA, Korlym, JARDIANCE, Kerendia, CAPLYTA.
Industry payments across MD — which companies pay providers there.
